We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App





MEDLAB Middle East and Arab Health 2022 Edition Return as Co-Located Events for Healthcare and Laboratory Industries

By LabMedica International staff writers
Posted on 24 Jan 2022
Print article
Image: MEDLAB Middle East (Photo courtesy of Informa Markets)
Image: MEDLAB Middle East (Photo courtesy of Informa Markets)

Technology took centre stage at the 2022 edition of Arab Health and MEDLAB Middle East, the largest healthcare and laboratory exhibitions in the MENA region, organized by Informa Markets (London, UK).

The co-located events took place at the Dubai World Trade Centre from January 24-27 under the show themes of ‘United by business, forging ahead’ and ‘Connect with innovation that’s changing the face of diagnostics’. Both shows saw participants from nearly 160 countries and more than 60,000 attendees across the four days, with almost 4,000 exhibitors from the healthcare and laboratory industries.

More than 60 countries were represented, with over 20 dedicated country pavilions, making Arab Health and MEDLAB Middle East a genuinely global healthcare showcase. They included the UAE, Israel, Lebanon, Turkey, and a host of European countries such as the UK, Switzerland, Germany, Italy, France, Spain, Portugal, Slovenia, Hungary, Czech Republic, Poland, and Belgium. Russia, China, Taiwan, Japan, Korea, India, the US and Canada also had several exhibitors showcasing the latest technology and innovation through a range of healthcare products. Each pavilion hosted between 16 and 33 healthcare-related companies. In addition, the European Innovation Council Pavilion hosted 20 selected companies from across the healthcare landscape.

Underscoring the focus on technology, Arab Health 2022 featured the new Healthcare Transformation Zone which explored the latest tech advancements from global innovators and disruptors. The popular start-up competition, Innov8 Talks returned and featured 24 companies showcasing unique and innovative solutions. Rounding out the Transformation Zone was the launch of the Product Showcase segment, where a range of companies showcased ground-breaking innovations shaping the future of the healthcare and laboratory industries.

In another first for both events was the launch of the Future Health Summit. The high-level event was attended by over 150 senior government healthcare officials, CEOs and visionaries, from across the globe. As part of the Arab Health Congress, more than 550 regional and international speakers and over 2,500 delegates participated in 12 Continuing Medical Education (CME). With a total of nine conferences, MEDLAB Middle East Congress remains one of the largest CME accredited multi-track medical laboratory congresses globally, featuring over 100 renowned laboratory champions from around the world. Eight conferences took place live, in-person, and online, the new bonus track, Future of Lab.

"Arab Health and Medlab Middle East will once again reiterate the importance of the healthcare and laboratory industries as we continue to address the challenges posed by COVID-19 and provide a platform for developing solutions to overcome the pandemic," said Solenne Singer, Group Director for Informa Markets. "We have witnessed a clear uptick in demand from both buyers and exhibitors eager to meet in-person, to see firsthand the latest technology and innovation on the market, while also hearing from industry professionals from around the world on the latest trends and insights. This year, both events will be integral to ongoing global recovery, and we look forward to welcoming the industry to Dubai."

Related Links:
Informa Markets 

Gold Member
Hematology Analyzer
Swelab Lumi
New
Gold Member
ZIKA Virus Test
ZIKA ELISA IgG
New
Chagas Disease Test
Simple/Stick Chagas/WB
New
Testosterone Assay
Testosterone ELISA (REF 21-02)

Print article

Channels

Molecular Diagnostics

view channel
Image: The kit includes a container with a film, a compact optical device for attaching a smartphone, and a diagnostic app (Photo courtesy of KIST)

Urine-Based Bladder Cancer Diagnostic Kit to Reduce Need for Unnecessary Cystoscopies

Bladder cancer has a high cure rate of over 90% when detected early, but it is characterized by a recurrence rate of 70%, which requires continuous monitoring. Late-stage detection often results in major... Read more

Microbiology

view channel
Image: The QIAstat-Dx mini gastrointestinal panel has secured U.S. clearance to support year-round outpatient care (Photo courtesy of QIAGEN)

Syndromic Panel Provides Fast Answers for Outpatient Diagnosis of Gastrointestinal Conditions

Acute infectious gastroenteritis is a major cause of outpatient visits and hospitalizations in the U.S., with over 179 million cases estimated annually. Now, a new gastrointestinal panel designed to provide... Read more

Pathology

view channel
Image: The AI tool can search through data and histology images for much more precise information on cancer treatment effectiveness (Photo courtesy of Shutterstock)

AI Tool Analyzes 30K Data Points Per Medical Imaging Pixel in Cancer Search

A new artificial intelligence (AI)-powered tool can detect cell-level characteristics of cancer by analyzing data from very small tissue samples, some as tiny as 400 square micrometers, equivalent to the... Read more

Technology

view channel
Image: Human tear film protein sampling methods (Photo courtesy of Clinical Proteomics. 2024 Mar 13;21:23. doi: 10.1186/s12014-024-09475-8)

New Lens Method Analyzes Tears for Early Disease Detection

Bodily fluids, including tears and saliva, carry proteins that are released from different parts of the body. The presence of specific proteins in these biofluids can be a sign of health issues.... Read more

Industry

view channel
Image: The game-changing immunoassay diagnostics platform delivers results from whole blood sample in 10 minutes (Photo courtesy of SpinChip)

bioMérieux Acquires Norwegian Immunoassay Start-Up SpinChip Diagnostics

bioMérieux (Marcy l’Étoile, France) has agreed to acquire SpinChip Diagnostics (Oslo, Norway), the developer of a game-changing immunoassay diagnostics platform. The small benchtop analyzer is well adapted... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.